LOGIN  |  REGISTER
Chimerix

Recent Insider Transactions - Rigel Pharmaceuticals (NASDAQ: RIGL)

Follow NASDAQ:RIGL Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ RIGL Rigel Pharmaceuticals
Schorno Dean L / officer: EVP & Chief Financial Officer
03/17/2025
Buy
$12.70
7,850
$100K
7,850
NASDAQ RIGL Rigel Pharmaceuticals
Schorno Dean L / officer: EVP & Chief Financial Officer
03/17/2025
Buy
$35.40
5,625
$199K
5,625
NASDAQ RIGL Rigel Pharmaceuticals
Santos David A / officer: EVP, Chief Commercial Officer
03/17/2025
Buy
$12.70
7,850
$100K
7,850
NASDAQ RIGL Rigel Pharmaceuticals
Santos David A / officer: EVP, Chief Commercial Officer
03/17/2025
Buy
$35.40
6,875
$243K
6,875
NASDAQ RIGL Rigel Pharmaceuticals
Rojkjaer Lisa / officer: EVP, Chief Medical Officer
03/17/2025
Buy
$14.90
9,375
$140K
9,375
NASDAQ RIGL Rigel Pharmaceuticals
RODRIGUEZ RAUL R / director, officer: CEO, President
03/17/2025
Buy
$12.70
30,000
$381K
30,000
NASDAQ RIGL Rigel Pharmaceuticals
RODRIGUEZ RAUL R / director, officer: CEO, President
03/17/2025
Buy
$35.40
26,250
$929K
26,250
NASDAQ RIGL Rigel Pharmaceuticals
Furey Raymond J. / officer: EVP, GC, CCO & Corp Sec
03/17/2025
Buy
$9.00
9,375
$84K
9,375
NASDAQ RIGL Rigel Pharmaceuticals
Furey Raymond J. / officer: EVP, GC, CCO & Corp Sec
03/17/2025
Buy
$12.70
7,850
$100K
7,850
NASDAQ RIGL Rigel Pharmaceuticals
Frohlich Mark W / director
03/06/2025
Buy
$19.70
12,000
$236K
12,000

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous